These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11522491)

  • 1. Controlled release of tramadol hydrochloride from matrices prepared using glyceryl behenate.
    Obaidat AA; Obaidat RM
    Eur J Pharm Biopharm; 2001 Sep; 52(2):231-5. PubMed ID: 11522491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous twin screw melt granulation of glyceryl behenate: Development of controlled release tramadol hydrochloride tablets for improved safety.
    Keen JM; Foley CJ; Hughey JR; Bennett RC; Jannin V; Rosiaux Y; Marchaud D; McGinity JW
    Int J Pharm; 2015 Jun; 487(1-2):72-80. PubMed ID: 25839417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation of a modified-release pregabalin tablet using hot-melt coating with glyceryl behenate.
    Jeong KH; Woo HS; Kim CJ; Lee KH; Jeon JY; Lee SY; Kang JH; Lee S; Choi YW
    Int J Pharm; 2015 Nov; 495(1):1-8. PubMed ID: 26315121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of processing variables on the mechanical and release properties of tramadol matrix tablets incorporating Cissus populnea gum as controlled release excipient.
    Adeleye OA; Femi-Oyewo MN; Odeniyi MA
    Polim Med; 2014; 44(4):209-20. PubMed ID: 25932902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation of bi-layer matrix tablets of tramadol hydrochloride: Comparison of rate retarding ability of the incorporated hydrophilic polymers.
    Arif H; Al-Masum A; Sharmin F; Reza S; Sm Islam SA
    Pak J Pharm Sci; 2015 May; 28(3):855-61. PubMed ID: 26004717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled release formulation of tramadol hydrochloride using hydrophilic and hydrophobic matrix system.
    Tiwari SB; Murthy TK; Pai MR; Mehta PR; Chowdary PB
    AAPS PharmSciTech; 2003; 4(3):E31. PubMed ID: 14621963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of hydrophilic natural gums in formulation of sustained-release matrix tablets of tramadol hydrochloride.
    Varshosaz J; Tavakoli N; Kheirolahi F
    AAPS PharmSciTech; 2006 Mar; 7(1):E24. PubMed ID: 16584155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro controlled release of sodium ferulate from Compritol 888 ATO-based matrix tablets.
    Li FQ; Hu JH; Deng JX; Su H; Xu S; Liu JY
    Int J Pharm; 2006 Nov; 324(2):152-7. PubMed ID: 16837152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation Development and Optimization of Matrix Tablet of Tramadol Hydrochloride.
    Deb P; Singha J; Chanda I; Chakraborty P
    Recent Pat Drug Deliv Formul; 2017; 11(1):19-27. PubMed ID: 27712568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and dissolution kinetics study of hydrophilic matrix tablets with tramadol hydrochloride and different co-processed dry binders.
    Komersová A; Lochař V; Myslíková K; Mužíková J; Bartoš M
    Eur J Pharm Sci; 2016 Dec; 95():36-45. PubMed ID: 27496049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of Sustained Release Tablet with Minimized Usage of Glyceryl Behenate Using Post-Heating Method.
    Kang C; Lee JH; Kim DW; Lee BJ; Park JB
    AAPS PharmSciTech; 2018 Oct; 19(7):3067-3075. PubMed ID: 30094721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of tablet structure on controlled release from supersaturating solid dispersions containing glyceryl behenate.
    Keen JM; Hughey JR; Bennett RC; Jannin V; Rosiaux Y; Marchaud D; McGinity JW
    Mol Pharm; 2015 Jan; 12(1):120-6. PubMed ID: 25347621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of tramadol release from a hydrophobic matrix: implications of formulations and processing variables.
    Sudha BS; Sridhar BK; Srinatha A
    AAPS PharmSciTech; 2010 Mar; 11(1):433-40. PubMed ID: 20300896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The delivery mechanism of micro-porous osmotic pump tablets].
    Zhao XL; Li Q; Gong XF; Li SM
    Yao Xue Xue Bao; 2007 Feb; 42(2):226-30. PubMed ID: 17518057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compressibility of tableting materials and properties of tablets with glyceryl behenate.
    Mužíková J; Muchová S; Komersová A; Lochař V
    Acta Pharm; 2015 Mar; 65(1):91-8. PubMed ID: 25781708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and characterization of Compritol 888 ATO matrix tablets for the sustained release of diclofenac sodium.
    Roberts M; Pulcini L; Mostafa S; Cuppok-Rosiaux Y; Marchaud D
    Pharm Dev Technol; 2015 Jun; 20(4):507-12. PubMed ID: 24354893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipids bearing extruded-spheronized pellets for extended release of poorly soluble antiemetic agent-Meclizine HCl.
    Qazi F; Shoaib MH; Yousuf RI; Nasiri MI; Ahmed K; Ahmad M
    Lipids Health Dis; 2017 Apr; 16(1):75. PubMed ID: 28403892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and optimization of glyceryl behenate-based highly porous pellets containing cilostazol.
    Hwang KM; Byun W; Cho CH; Park ES
    Pharm Dev Technol; 2018 Jun; 23(5):540-551. PubMed ID: 27718780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of formulation composition on the properties of controlled release tablets prepared by roller compaction.
    Hariharan M; Wowchuk C; Nkansah P; Gupta VK
    Drug Dev Ind Pharm; 2004 Jul; 30(6):565-72. PubMed ID: 15285329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of ethylcellulose as matrices for controlled release drug delivery.
    Quadir MA; Chanda E; Haider SS; Reza MD; Datta BK
    Pak J Pharm Sci; 2005 Apr; 18(2):29-34. PubMed ID: 16431395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.